Advertisement

Ads Placeholder
Loading...

OS Therapies Incorporated

OSTX•AMEX
Healthcare
Biotechnology
$1.36
$0.00(0.00%)
U.S. Market opens in 54h 5m

OS Therapies Incorporated (OSTX) Stock Overview

Explore OS Therapies Incorporated’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap47.9M
P/E Ratio-0.00
EPS (TTM)$-0.98
ROE-19238.57%
Fundamental Analysis

AI Price Forecasts

1 Month$1.16
3 Months$1.35
1 Year Target$1.34

OSTX Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of OS Therapies Incorporated (OSTX) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 44.73, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $1.34.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.00 and a market capitalization of 47.9M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
-1.45%
1-Month Change
-2.86%
3-Month Change
1.49%
6-Month Change
-32.67%
Year-to-Date (YTD) Change
1.49%
1-Year Change
-11.69%
3-Year Change
-45.82%
5-Year Change
-45.82%
All-Time (Max) Change
-45.82%

Contact Information

https://ostherapies.com
410-297-7793
115 Pullman Crossing Road, Rockville, MD, 21638

Company Facts

40 Employees
IPO DateAug 1, 2024
CountryUS
Actively Trading

Frequently Asked Questions